319
Participants
Start Date
May 31, 2006
Primary Completion Date
May 31, 2010
Study Completion Date
September 30, 2010
Celecoxib
Celecoxib 400 mg twice daily, orally, starting on the same day as palliative chemotherapy. Maximum duration of treatment is one year. Treatment should be terminated earlier in case of disease progression, unacceptable toxicity, or if the patient wants to stop treatment.
Placebo
One capsule twice daily, starting on the same day as palliative chemotherapy. Maximum duration of treatment is one year. Treatment should be terminated earlier in case of disease progression, unacceptable toxicity, or if the patient wants to stop treatment.
Department of Pulmonary Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg
Section of Pulmonary Medicine, Ryhov County Hospital, Jönköping
Section of Pulmonary Medicine and Allergology, County Hospital of Kalmar, Kalmar
Department of Pulmonary Medicine, University Hospital, Linköping
Department of Pulmonary Medicine and Allergy, Lund University Hospital, Lund
Section of Pulmonary Medicine, Malmö University Hospital, Malmo
Department of Pulmonary Medicine, Örebro University Hospital, Örebro
Department of Medicine, Skövde Hospital/KSS, Skövde
Department of Medicine, Trollhättan Hospital/NÄL, Trollhättan
Department of Medicine, Uddevalla Hospital, Uddevalla
Department of Pulmonary medicine, Umeå University Hospital, Umeå
Department of Pulmonary Medicine and Allergology, Uppsala University Hospital, Uppsala
Department of Medicine, Ystad Hospital, Ystad
Collaborators (1)
Swedish Lung Cancer Study Group
NETWORK
Pfizer
INDUSTRY
University Hospital, Linkoeping
OTHER